Overcoming Accessibility Challenges In International Clinical Trials

Clinical trials increasingly have international dimensions. Whether a drug developer wants to gain approval to distribute the medication in multiple countries or a research team wants to increase the diversity of participants, the international element makes clinical trials more complex.

“To test new treatments with enough patients to be confident about the results, clinical research should not be limited to one institution, or even one country,” writes the team at Breast International Group. “The single strongest opportunity for success comes from combining resources and multi-disciplinary expertise from around the globe to establish research priorities, improve collaboration, and reduce unnecessary duplication of effort to generate results more quickly.”

Any challenge in clinical trials can be overcome, but a few critical international issues are limiting the accessibility of clinical trials and hindering their results. When researching abroad, be prepared to tackle these common barriers sponsors and clinical research organizations are working to resolve.